Expressive Writing for Cancer Survivors

Duke University

Status: Completed

Conditions: Cancer Survivors

Treatments: Behavioral: Expressive writing

Study type: Interventional

Funder types: Other

Identifiers

NCT04171609

Pro00101278

Details and patient eligibility

About

The purpose of this study is to determine whether a 1-day expressive writing intervention for adult cancer survivors improves resilience scores as measured by the Connor-Davidson Resilience Scale (CD-RISC).

Full description

The purpose of this study is to determine whether a 1-day expressive writing intervention for adult cancer survivors improves resilience scores as measured by the Connor-Davidson Resilience Scale (CD-RISC).

Enrollment: 14 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Have ever received a cancer diagnosis
• Have completed cancer treatment (e.g., surgery, radiation, or chemotherapy)
• Are able to speak, read, write, and understand English
• Are cognitively able to provide consent
• Are able to travel to Durham to participate in the 1-day writing intervention

Exclusion criteria

-Cancer diagnosis was skin cancer that did not require additional treatment after surgical removal

Trial design

Primary purpose: Supportive Care

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

14 participants in 1 patient group

Cancer survivors

Experimental group

Description:

Adult survivors of any kind of cancer (except for minor skin cancer) are eligible to participate

Treatment:

Behavioral: Expressive writing